Details
Stereochemistry | ACHIRAL |
Molecular Formula | C7H6O3 |
Molecular Weight | 138.1207 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
OC(=O)C1=C(O)C=CC=C1
InChI
InChIKey=YGSDEFSMJLZEOE-UHFFFAOYSA-N
InChI=1S/C7H6O3/c8-6-4-2-1-3-5(6)7(9)10/h1-4,8H,(H,9,10)
Molecular Formula | C7H6O3 |
Molecular Weight | 138.1207 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:12:43 UTC 2023
by
admin
on
Fri Dec 15 15:12:43 UTC 2023
|
Record UNII |
O414PZ4LPZ
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
CFR |
21 CFR 358.710
Created by
admin on Fri Dec 15 15:12:43 UTC 2023 , Edited by admin on Fri Dec 15 15:12:43 UTC 2023
|
||
|
CFR |
21 CFR 333.310
Created by
admin on Fri Dec 15 15:12:43 UTC 2023 , Edited by admin on Fri Dec 15 15:12:43 UTC 2023
|
||
|
NCI_THESAURUS |
C257
Created by
admin on Fri Dec 15 15:12:43 UTC 2023 , Edited by admin on Fri Dec 15 15:12:43 UTC 2023
|
||
|
NCI_THESAURUS |
C52588
Created by
admin on Fri Dec 15 15:12:43 UTC 2023 , Edited by admin on Fri Dec 15 15:12:43 UTC 2023
|
||
|
CFR |
21 CFR 358.510
Created by
admin on Fri Dec 15 15:12:43 UTC 2023 , Edited by admin on Fri Dec 15 15:12:43 UTC 2023
|
||
|
WHO-VATC |
QD01AE12
Created by
admin on Fri Dec 15 15:12:44 UTC 2023 , Edited by admin on Fri Dec 15 15:12:44 UTC 2023
|
||
|
CFR |
21 CFR 862.3830
Created by
admin on Fri Dec 15 15:12:43 UTC 2023 , Edited by admin on Fri Dec 15 15:12:43 UTC 2023
|
||
|
EPA PESTICIDE CODE |
76602
Created by
admin on Fri Dec 15 15:12:43 UTC 2023 , Edited by admin on Fri Dec 15 15:12:43 UTC 2023
|
||
|
CFR |
21 CFR 358.720
Created by
admin on Fri Dec 15 15:12:43 UTC 2023 , Edited by admin on Fri Dec 15 15:12:43 UTC 2023
|
||
|
WHO-VATC |
QS01BC08
Created by
admin on Fri Dec 15 15:12:44 UTC 2023 , Edited by admin on Fri Dec 15 15:12:44 UTC 2023
|
||
|
WHO-ATC |
S01BC08
Created by
admin on Fri Dec 15 15:12:43 UTC 2023 , Edited by admin on Fri Dec 15 15:12:43 UTC 2023
|
||
|
CFR |
21 CFR 358.110
Created by
admin on Fri Dec 15 15:12:43 UTC 2023 , Edited by admin on Fri Dec 15 15:12:43 UTC 2023
|
||
|
FDA ORPHAN DRUG |
359211
Created by
admin on Fri Dec 15 15:12:43 UTC 2023 , Edited by admin on Fri Dec 15 15:12:43 UTC 2023
|
||
|
WHO-VATC |
QM02AC99
Created by
admin on Fri Dec 15 15:12:44 UTC 2023 , Edited by admin on Fri Dec 15 15:12:44 UTC 2023
|
||
|
JECFA EVALUATION |
2-HYDROXYBENZOIC ACID
Created by
admin on Fri Dec 15 15:12:43 UTC 2023 , Edited by admin on Fri Dec 15 15:12:43 UTC 2023
|
||
|
WHO-ATC |
D01AE12
Created by
admin on Fri Dec 15 15:12:43 UTC 2023 , Edited by admin on Fri Dec 15 15:12:43 UTC 2023
|
||
|
WHO-ESSENTIAL MEDICINES LIST |
13.4
Created by
admin on Fri Dec 15 15:12:44 UTC 2023 , Edited by admin on Fri Dec 15 15:12:44 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
9525
Created by
admin on Fri Dec 15 15:12:44 UTC 2023 , Edited by admin on Fri Dec 15 15:12:44 UTC 2023
|
PRIMARY | |||
|
891
Created by
admin on Fri Dec 15 15:12:43 UTC 2023 , Edited by admin on Fri Dec 15 15:12:43 UTC 2023
|
PRIMARY | |||
|
672
Created by
admin on Fri Dec 15 15:12:43 UTC 2023 , Edited by admin on Fri Dec 15 15:12:43 UTC 2023
|
PRIMARY | |||
|
O414PZ4LPZ
Created by
admin on Fri Dec 15 15:12:43 UTC 2023 , Edited by admin on Fri Dec 15 15:12:43 UTC 2023
|
PRIMARY | |||
|
338
Created by
admin on Fri Dec 15 15:12:43 UTC 2023 , Edited by admin on Fri Dec 15 15:12:43 UTC 2023
|
PRIMARY | |||
|
9522
Created by
admin on Fri Dec 15 15:12:43 UTC 2023 , Edited by admin on Fri Dec 15 15:12:43 UTC 2023
|
ALTERNATIVE | |||
|
1609002
Created by
admin on Fri Dec 15 15:12:43 UTC 2023 , Edited by admin on Fri Dec 15 15:12:43 UTC 2023
|
PRIMARY | |||
|
Salicylic Acid
Created by
admin on Fri Dec 15 15:12:43 UTC 2023 , Edited by admin on Fri Dec 15 15:12:43 UTC 2023
|
PRIMARY | |||
|
SUB15180MIG
Created by
admin on Fri Dec 15 15:12:43 UTC 2023 , Edited by admin on Fri Dec 15 15:12:43 UTC 2023
|
PRIMARY | |||
|
SALICYLIC ACID
Created by
admin on Fri Dec 15 15:12:44 UTC 2023 , Edited by admin on Fri Dec 15 15:12:44 UTC 2023
|
PRIMARY | |||
|
69-72-7
Created by
admin on Fri Dec 15 15:12:43 UTC 2023 , Edited by admin on Fri Dec 15 15:12:43 UTC 2023
|
PRIMARY | |||
|
Medical uses of salicylic acid
Created by
admin on Fri Dec 15 15:12:44 UTC 2023 , Edited by admin on Fri Dec 15 15:12:44 UTC 2023
|
PRIMARY | |||
|
200-712-3
Created by
admin on Fri Dec 15 15:12:43 UTC 2023 , Edited by admin on Fri Dec 15 15:12:43 UTC 2023
|
PRIMARY | |||
|
D020156
Created by
admin on Fri Dec 15 15:12:43 UTC 2023 , Edited by admin on Fri Dec 15 15:12:43 UTC 2023
|
PRIMARY | |||
|
30762
Created by
admin on Fri Dec 15 15:12:43 UTC 2023 , Edited by admin on Fri Dec 15 15:12:43 UTC 2023
|
PRIMARY | |||
|
4306
Created by
admin on Fri Dec 15 15:12:43 UTC 2023 , Edited by admin on Fri Dec 15 15:12:43 UTC 2023
|
PRIMARY | |||
|
180
Created by
admin on Fri Dec 15 15:12:43 UTC 2023 , Edited by admin on Fri Dec 15 15:12:43 UTC 2023
|
PRIMARY | |||
|
100000090038
Created by
admin on Fri Dec 15 15:12:44 UTC 2023 , Edited by admin on Fri Dec 15 15:12:44 UTC 2023
|
PRIMARY | |||
|
2416
Created by
admin on Fri Dec 15 15:12:43 UTC 2023 , Edited by admin on Fri Dec 15 15:12:43 UTC 2023
|
PRIMARY | |||
|
16914
Created by
admin on Fri Dec 15 15:12:43 UTC 2023 , Edited by admin on Fri Dec 15 15:12:43 UTC 2023
|
PRIMARY | |||
|
O414PZ4LPZ
Created by
admin on Fri Dec 15 15:12:43 UTC 2023 , Edited by admin on Fri Dec 15 15:12:43 UTC 2023
|
PRIMARY | |||
|
m9739
Created by
admin on Fri Dec 15 15:12:43 UTC 2023 , Edited by admin on Fri Dec 15 15:12:43 UTC 2023
|
PRIMARY | Merck Index | ||
|
C61934
Created by
admin on Fri Dec 15 15:12:43 UTC 2023 , Edited by admin on Fri Dec 15 15:12:43 UTC 2023
|
PRIMARY | |||
|
SALICYLIC ACID
Created by
admin on Fri Dec 15 15:12:44 UTC 2023 , Edited by admin on Fri Dec 15 15:12:44 UTC 2023
|
PRIMARY | Description: Colourless crystals, usually needle-like, or a white, crystalline powder; odourless. Solubility: Slightly soluble in water; soluble in 4 parts of ethanol (~750 g/l) TS and in 3 parts of ether R. Category: Keratolytic. Storage: Salicylic acid should be kept in a well-closed container. Definition: Salicylic acid contains not less than 99.0% and not more than 101.0% of C7H6O3, calculated with reference to the dried substance. | ||
|
CHEMBL424
Created by
admin on Fri Dec 15 15:12:43 UTC 2023 , Edited by admin on Fri Dec 15 15:12:43 UTC 2023
|
PRIMARY | |||
|
DB00936
Created by
admin on Fri Dec 15 15:12:43 UTC 2023 , Edited by admin on Fri Dec 15 15:12:43 UTC 2023
|
PRIMARY | |||
|
DTXSID7026368
Created by
admin on Fri Dec 15 15:12:43 UTC 2023 , Edited by admin on Fri Dec 15 15:12:43 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
SALT/SOLVATE -> PARENT |
|
||
|
SALT/SOLVATE -> PARENT |
|
||
|
SALT/SOLVATE -> PARENT |
|
||
|
SALT/SOLVATE -> PARENT |
|
||
|
SALT/SOLVATE -> PARENT |
|
||
|
SALT/SOLVATE -> PARENT |
|
||
|
SALT/SOLVATE -> PARENT |
|
||
|
SALT/SOLVATE -> PARENT |
|
||
|
SALT/SOLVATE -> PARENT |
|
||
|
SALT/SOLVATE -> PARENT |
|
||
|
PARENT -> CONSTITUENT ALWAYS PRESENT |
Salicylic acid content for water extract of plant callus was 3.22+/-0.06 as expressed as mg/100 g of dry base of extract.
For the analysis of phenolic acids, a Nova pack C18 UG120 equipped with a Guard column, a JASCO HPLC system consisting of a column oven, a UV-Vis diode array detector set at 280 nm, a Liquid chromatography pump and a ChromNAV software program were used.
|
||
|
SALT/SOLVATE -> PARENT |
|
||
|
SALT/SOLVATE -> PARENT |
|
||
|
SALT/SOLVATE -> PARENT |
|
||
|
SALT/SOLVATE -> PARENT |
|
||
|
SALT/SOLVATE -> PARENT |
|
||
|
SALT/SOLVATE -> PARENT |
|
||
|
SALT/SOLVATE -> PARENT |
|
||
|
SALT/SOLVATE -> PARENT |
|
||
|
PARENT -> CONSTITUENT ALWAYS PRESENT |
|
||
|
PARENT -> CONSTITUENT ALWAYS PRESENT |
|
||
|
SALT/SOLVATE -> PARENT |
|
||
|
SALT/SOLVATE -> PARENT |
|
||
|
SALT/SOLVATE -> PARENT |
|
||
|
SALT/SOLVATE -> PARENT |
|
||
|
SALT/SOLVATE -> PARENT |
|
||
|
SALT/SOLVATE -> PARENT |
|
||
|
SALT/SOLVATE -> PARENT |
|
||
|
SALT/SOLVATE -> PARENT |
|
||
|
SALT/SOLVATE -> PARENT |
|
||
|
SALT/SOLVATE -> PARENT |
|
||
|
SALT/SOLVATE -> PARENT |
|
||
|
SALT/SOLVATE -> PARENT |
|
||
|
SALT/SOLVATE -> PARENT |
|
||
|
TRANSPORTER -> INHIBITOR | |||
|
SALT/SOLVATE -> PARENT |
|
||
|
SALT/SOLVATE -> PARENT |
|
||
|
SALT/SOLVATE -> PARENT |
|
||
|
SALT/SOLVATE -> PARENT |
|
||
|
SALT/SOLVATE -> PARENT |
|
||
|
DERIVATIVE -> PARENT |
|
||
|
SALT/SOLVATE -> PARENT |
|
||
|
SALT/SOLVATE -> PARENT |
|
||
|
SALT/SOLVATE -> PARENT |
|
||
|
SALT/SOLVATE -> PARENT |
|
||
|
SALT/SOLVATE -> PARENT |
|
||
|
SALT/SOLVATE -> PARENT |
|
||
|
SALT/SOLVATE -> PARENT |
|
||
|
SALT/SOLVATE -> PARENT |
|
||
|
PARENT -> CONSTITUENT ALWAYS PRESENT |
|
||
|
SALT/SOLVATE -> PARENT |
|
||
|
SALT/SOLVATE -> PARENT |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
PRODRUG -> METABOLITE ACTIVE |
|
||
|
PARENT -> METABOLITE ACTIVE |
MINOR
URINE
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> IMPURITY |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
EP
|
||
|
PARENT -> IMPURITY |
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
|
||
|
IMPURITY -> PARENT |
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
Ph.Eur.; USP
|
||
|
IMPURITY -> PARENT |
INTERNATIONAL PHARMACOPEIA
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
PARENT -> IMPURITY |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
INTERNATIONAL PHARMACOPEIA
|
||
|
IMPURITY -> PARENT |
USP
|
||
|
PARENT -> IMPURITY |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
USP
|
||
|
PARENT -> IMPURITY |
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
PARENT -> IMPURITY |
Correction factors: for the calculation of contents, multiply the peak areas by 1.4
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
PARENT -> IMPURITY |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
|